SCHEMBL166930

SCHEMBL166930

CC1CC1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14947574 0.91
SCHEMBL14947601 0.79
SCHEMBL23645789 0.73
SCHEMBL19730167 0.73
SCHEMBL19730166 0.73
SCHEMBL20326654 0.73
SCHEMBL6554619 0.72
SCHEMBL18025439 0.72
SCHEMBL6555519 0.72
SCHEMBL1005236 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071411-B2 Inhibitors of HIF-2α and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2024-08-27 US disclosed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
US-20230159466-A1 INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. 2023-05-25 US disclosed
CN-112074521-B Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2022-08-09 CN disclosed
CN-112074521-A Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2020-12-11 CN disclosed
EP-2611802-B1 BICYCLIC AZA-HETEROCYCLES AND THEIR USE BAYER IP GMBH (DE) 2016-02-24 EP disclosed
CN-105294702-A Fused pyrrolocarbazoles and methods for the preparation thereof CEPHALON INC 2016-02-03 CN disclosed
US-9096592-B2 Bicyclic aza heterocycles, and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-08-04 US disclosed
CN-104788459-A Fused pyrrolocarbazoles and methods for preparation thereof CEPHALON INC 2015-07-22 CN disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
WO-2007006091-A1 POLYNUCLEOTIDE MARKER GENES AND THEIR EXPRESSION, FOR DIAGNOSIS OF ENDOTOXEMIA ATHLOMICS PTY LTD (AU) 2007-01-18 WO disclosed
EP-1711499-A2 FUSED PYRROLOCARBAZOLES AND METHODS FOR THE PREPARATION THEREOF CEPHALON, INC. (US) 2006-10-18 EP disclosed
US-7022707-B2 Piperazine derivatives HOFFMAN-LA ROCHE INC. (US) 2006-04-04 US disclosed
WO-2005063764-A2 FUSED PYRROLOCARBAZOLES AND METHODS FOR THE PREPARATION THEREOF CEPHALON, INC. (US) 2005-07-14 WO disclosed
US-20050137245-A1 Novel fused pyrrolocarbazoles CEPHALON, INC. 2005-06-23 US disclosed
US-20040235859-A1 Novel piperazine derivatives ADAMS DAVID REGINALD (GB) 2004-11-25 US disclosed
EP-1343775-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-09-17 EP disclosed
US-20020143020-A1 Novel piperazine derivatives VERNALIS RESEARCH LIMITED (GB) 2002-10-03 US disclosed
WO-2002048124-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-06-20 WO disclosed
US-4511566-A ANALGESICS PIERRE FABRE S.A. (FR) 1985-04-16 US disclosed